How They Work

• Retatrutide: A "triple-G" receptor agonist that simultaneously activates GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors to suppress appetite, enhance insulin secretion, and boost energy expenditure.

• Cagrilintide: A long-acting amylin analogue that mimics the natural pancreatic hormone amylin to promote satiety in the hindbrain and slow gastric emptying. 

The Combination Concept

While combining an amylin analogue with a multi-receptor backbone mirrors successful development strategies like CagriSema (cagrilintide plus semaglutide), a direct cagrilintide and retatrutide co-administered stack remains largely theoretical. Most published data evaluate these agents individually in clinical trials rather than as a paired combination.